PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII), President and COO Alan P. Timmins will present the company’s business strategy and clinical development update at two investor conferences today.
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII), President and COO Alan P. Timmins will present the company’s business strategy and clinical development update at two investor conferences today.